Newer Immunotherapy Options for Relapsed/Refractory Follicular Lymphoma

Source: Acclimating Practice to the Current Treatment Landscape in Follicular Lymphoma: Emerging Evidence and Recent Results
Download Slideset
Download this slideset from a live CCO webinar for an expert overview of recent updates in R/R FL with a focus on bispecific antibodies and CAR T-cell therapy, including data from ASH 2022.
Ian W. Flinn, MD, PhD
Laurie H. Sehn, MD, MPH
Format: Microsoft PowerPoint (.ppt)
File Size: 933 KB
Released: February 2, 2023

Acknowledgements

Provided by Clinical Care Options, LLC.
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Genentech, a member of the Roche Group
MEI Pharma Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings